Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. - Wikidata - awgldk - TriplyDB

Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features.

Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features.

http://www.wikidata.org/entity/Q33584274

about

TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease CpG island methylation in colorectal cancer: past, present and future Integration of genome scale data for identifying new players in colorectal cancer Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression Whole-genome methylation analysis of benign and malignant colorectal tumours Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum The influence of aging, environmental exposures and local sequence features on the variation of DNA methylation in blood Integrative clustering methods for high-dimensional molecular data.Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data A genome-wide DNA methylation study in colorectal carcinoma.Developmental genes targeted for epigenetic variation between twin-twin transfusion syndrome children.The CpG island methylator phenotype (CIMP) in colorectal cancer.Genome-wide DNA methylation profiling of CpG islands in a morpholino anthracycline derivative-resistant leukemia cell line: p38α as a novel candidate for resistance.ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer Semi-supervised recursively partitioned mixture models for identifying cancer subtypes.A CpG island methylator phenotype of colorectal cancer that is contiguous with conventional adenomas, but not serrated polyps.Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer.DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach.Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta.Tracking the Correlation Between CpG Island Methylator Phenotype and Other Molecular Features and Clinicopathological Features in Human Colorectal Cancers: A Systematic Review and Meta-Analysis.CpG Island Methylation, Microsatellite Instability, and BRAF Mutations and Their Clinical Application in the Treatment of Colon Cancer.Evaluation of the left-to-right shift of colon tumors in Iran: Is the trend changing?A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification Lineage tracing reveals multipotent stem cells maintain human adenomas and the pattern of clonal expansion in tumor evolution.Epigenetics and colorectal cancer pathogenesis Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women.The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumors.Important molecular genetic markers of colorectal cancer.Individualized therapy for metastatic colorectal cancer.Genetic unraveling of colorectal cancer.Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.Genomic and transcriptomic heterogeneity of colorectal tumors arising in Lynch Syndrome.Genome-wide screening for understanding the role of DNA methylation in colorectal cancer.Epigenetic Heterogeneity of B-Cell Lymphoma: DNA Methylation, Gene Expression and Chromatin States.A panel of genes methylated with high frequency in colorectal cancer Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer.

P2860

Q24288715-B2F60AB0-DB04-4B64-ACCE-4F778B13DF61 Q24289344-945D0B75-DB08-4C6E-B73C-110F2C875D59 Q24597977-AF540FD8-EAE6-4E93-95A2-7E4479434AF1 Q26774701-B5E29523-8B67-4AD4-BD55-477230434729 Q26852716-16B418FE-12D2-439C-B00F-B582884F443C Q28109367-C786AA0C-EAD3-4A7C-9C7B-950D7751B42E Q28262150-EAC2626B-F49C-4B4B-B90F-04E70AC49A0A Q28391041-4AE91ED1-A28A-45EA-BEB8-3B956864FE74 Q30854282-0D0F04D2-A11B-4FA3-B09D-4E9B115E7745 Q30956148-6982C1A4-1536-4663-88DE-70BC07DA0946 Q31020320-406ADD42-2ABD-471E-99A5-ADACB936AD72 Q33590312-2CD48AC1-DCFE-4CCB-BE96-F2C9C6D975EE Q33596629-9D5C52A2-1177-4970-8D01-47418963894C Q33771409-4325BAEA-158F-418D-91F6-C575A9B6B05E Q33828288-86B54E27-5C26-4579-92C0-B479586D3761 Q34180853-79359EF3-A6AF-4EEA-A72A-CE5A5B89D555 Q34293192-12085001-D4C9-4E06-A060-F9DEC91CF411 Q34358286-0E4AC2D5-17B4-4B5B-B3BE-BD84298D2CFD Q34769855-0CA30E4B-BEBD-435C-A062-8CB6B02BC9CF Q35120213-B2599DFF-408F-48EC-9957-85E6890C5A9B Q35132907-4DEEB54B-DC2C-475E-BDEE-EB16BCF1C411 Q35208036-CEAB9662-FF36-42C1-8488-002352032B74 Q35756857-3C0E489C-1927-47FE-AB20-D0CA4F4457D5 Q35952149-9B8FF01C-8719-4147-9163-2305A642D967 Q36075933-0C7D7C0B-8B78-4E28-9C13-51780E7819E0 Q36560765-FB849C84-11AA-4CCF-A4E7-7B41BCF9CE04 Q36974863-3DB6380C-1878-4761-B2C3-913E6704AF86 Q36991078-FFEFD11B-CEAA-46AC-967C-D9C2E0ED2D46 Q37061792-491D75FE-B5B4-408C-B6AA-98CE5DD24719 Q37170000-EA216DC1-70E0-45CE-85F3-F37E2067E85F Q37288532-10AF700F-2B46-44F5-8580-3EFC6AF0CEA9 Q37619856-66D89AD8-C213-49D7-8C98-056B3F82A936 Q38092886-2B74BE34-1E04-46AD-855C-11ABE094871E Q38191462-2D90C171-55E0-4892-9170-D5F8466D0D04 Q38194582-1DF41DEB-6DEC-45F0-AC11-1D4CF99E1B63 Q38670418-E60EA382-7CA6-4A31-9817-A06A48DE5B89 Q39345973-3E868EAC-95DF-41F3-AF44-D89A19797CFE Q40539026-C62088F7-030B-4737-B22F-B904BB023FC4 Q41956283-5B7B5AB8-AE19-4ED6-9BC7-07B39E6C335F Q42175718-881FEC3D-95BD-47F1-B4CA-8608EC5EF33E

P2860

Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features.

http://www.wikidata.org/entity/Q33584274

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Comprehensive profiling of DNA ...... ogical and molecular features.

@ast

Comprehensive profiling of DNA ...... ogical and molecular features.

@en

Comprehensive profiling of DNA ...... ogical and molecular features.

@nl

type

label

Comprehensive profiling of DNA ...... ogical and molecular features.

@ast

Comprehensive profiling of DNA ...... ogical and molecular features.

@en

Comprehensive profiling of DNA ...... ogical and molecular features.

@nl

prefLabel

Comprehensive profiling of DNA ...... ogical and molecular features.

@ast

Comprehensive profiling of DNA ...... ogical and molecular features.

@en

Comprehensive profiling of DNA ...... ogical and molecular features.

@nl

P1433

Q33584274-7B67E713-42DA-4AC0-B44D-5A85F601800C

P1476

Q33584274-B329DB6F-29F1-45DC-ABD5-FEA5EFF35627

P2093

Q33584274-39EACFF7-BD33-4205-A9C9-E2CBDE6F89B9

Q33584274-579C2141-7ACF-4910-9AB2-C608131C605D

Q33584274-5CBDCA77-B845-4218-AFFC-7E9F54789967

Q33584274-907E4832-6207-4BD5-8EC4-BE99089F7DC1

Q33584274-9B3EA8B8-CF8E-4B41-8779-50B6ABD9ABE8

Q33584274-9F85E387-9399-4317-99B9-2EBAD820B9DE

Q33584274-A1CB0110-93E9-4637-B517-944A1DA4F881

Q33584274-DECF2B0F-64EF-4B9E-8601-A87B08270C19

Q33584274-E76A655A-63F8-46F2-9260-D81DCD0897D6

P2860

Q33584274-034E6153-80BF-445D-AC45-2ABC750E6C64

Q33584274-06DFCAFB-9F24-4D3F-B8C6-80175722ACC2

Q33584274-0B804637-C859-4D73-9BC4-1F2EA7AF2A52

Q33584274-0EE45F8B-FAC1-464C-94D1-38ABD4450BC5

Q33584274-191CF9AD-0E18-4242-989C-430E2368A46D

Q33584274-1E073C4E-4E95-4C37-82CD-4A3D58266E12

Q33584274-1F916C33-06E9-4637-8517-73B5A3D00602

Q33584274-31E6D967-FB10-4835-9F7C-9E2E463433A7

Q33584274-33F5FB4A-6F30-4E3F-B9E5-B57FF43CF7A8

Q33584274-3D063F4E-9B1C-4189-9EEA-8559E6BEE00F

P2888

Q33584274-BC61BFC5-2C52-47C1-B165-EC0589050E93

P304

Q33584274-5DF5EBD6-3FAD-406D-BF97-805F5CD6EFD5

P31

Q33584274-FB4772C0-32FA-4474-8618-52841858C92B

P356

Q33584274-B89929A3-0A65-4E26-BBEE-358D50BA169F

P407

Q33584274-F8DD453E-11BC-43BA-A120-814C48805095

P478

Q33584274-63AC8269-4128-45E4-9E6C-5BF08BFB292F

P50

Q33584274-6FF83325-4115-4A57-BCE3-339CB82AA32D

P577

Q33584274-4630A454-4FC9-44F7-856D-FB286C9F021D

P5875

Q33584274-9B298266-6EA7-4D84-AEB8-BB257D86624A

P6179

Q33584274-ED46E936-6026-4D1B-8B66-885B8CADA0CC

P698

Q33584274-057B93CC-9493-41D5-929D-91DC6CA0B614

P921

Q33584274-720A092B-97DB-4A38-B77C-A0730D3E17C5

Q33584274-A5AF52AF-4675-4E8D-AC5A-0C92A2EE9AC6

P932

Q33584274-B7CB412D-8229-4621-8FC1-8975C6070DAD

P356

1471-2407-10-227

P1433

P1476

Comprehensive profiling of DNA ...... ogical and molecular features.

@en

P2093

Aparna Vaithilingam

http://www.w3.org/2001/XMLSchema#string

Barry Iacopetta

http://www.w3.org/2001/XMLSchema#string

Cameron Platell

http://www.w3.org/2001/XMLSchema#string

Fabienne Grieu

http://www.w3.org/2001/XMLSchema#string

Marie Loh

http://www.w3.org/2001/XMLSchema#string

Natalia Liem

http://www.w3.org/2001/XMLSchema#string

Pei Li Lim

http://www.w3.org/2001/XMLSchema#string

Pei Woon Ang

http://www.w3.org/2001/XMLSchema#string

Wei Peng Yong

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status.

Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci

CpG island methylator phenotype in colorectal cancer

Control of developmental regulators by Polycomb in human embryonic stem cells

Specificities of heparan sulphate proteoglycans in developmental processes

Epigenetics in cancer

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

Epigenetic stem cell signature in cancer

Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection.

Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample

P2888

1471-2407-10-227

P304

227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-10-227

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44620910

http://www.w3.org/2001/XMLSchema#string

P6179

1049494132

http://www.w3.org/2001/XMLSchema#string

P698

20492682

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

DNA methylation

P932

2880997

http://www.w3.org/2001/XMLSchema#string